Physician
Pathology
Dr. Phuong T. Nguyen, MD
|
|
Give Review
Phuong Nguyen works in the field of Pathology. She went to Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine Phuong T. Nguyen, MD has written publications. She has 62 publications published with PubMed. The lastest publication is: 'False-negative rates of tumor metastases in the histologic examination of bone marrow.'
Publications
- Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
- Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients.
- Patients' rationale for declining participation in a cancer-Associated weight loss study.
- Exogenous hormone use, reproductive history and risk of adult myeloid leukaemia.
- Risk of adult acute and chronic myeloid leukemia With cigarette smoking and cessation.
- Self-organization of stabilized microtubules by both spindle and midzone mechanisms in Xenopus egg cytosol.
- Nonsteroidal Anti-inflammatory Drug and Acetaminophen Use and Risk of Adult Myeloid Leukemia.
- Practical Strategies to Circumvent and/or Surmount Six Barriers in Health Disparities Research: Observations from a Pilot Project Among Vietnamese Americans.
- Former Military Officers from the Republic of Vietnam Now Living in the United States (US): Exploring their Perceptions of the US Healthcare System.
- A qualitative study of the ramifications of rash from epidermal growth factor receptor (EGFR) inhibitors.
- Bone marrow morphologic features in polycythemia vera With JAK2 exon 12 mutations.
- The myelodysplastic syndromes.
- Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy.
- Isolated trisomy 15: a clonal chromosome abNormality in bone marrow with doubtful hematologic significance.
- A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
- WHIM syndrome.
- Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.
- Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenoCarcinoma.
- Helping people cope With bereavement: an opportunity for health care providers to link Web-based resources across Minnesota.
- Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central cancer treatment group.
- CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal Tract.
- Progression of chronic myeloid leukemia to blast crisis during treatment With imatinib mesylate.
- Tumor Necrosis Factor-alpha as a Treatment Target for the Cancer Anorexia/Weight Loss Syndrome.
- Diagnostic significance of detecting dysgranulopoiesis in chronic myeloid leukemia.
- On appetite and its loss.
- Persistent abNormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.
- The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.
- Collagen dePosition in HIV-1 infected lymphatic tissues and T cell homeostasis.
- SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during Stress.
- Membrane-bound (MUC1) and secretory (MUC2, MUC3, and MUC4) mucin gene expression in Human lung cancer.
- CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region.
- Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells.
- Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma.
- Interpreting flow cytometry for Hematologic neoplasms.
- Inhibition of tumor cell motility by the interferon-inducible GTPase MxA.
- Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin.
- SIRT3 interacts With the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression.
- BAT3 and SET1A form a complex With CTCFL/BORIS to modulate H3K4 histone dimethylation and gene expression.
- Chromosomal protein HMGN1 modulates the expression of N-cadherin.
- Can pathology residents be trained to perform adequate bone marrow biopsies?
- Using the absolute neutrophil count as a stand-alone test in a hematology/oncology clinic: an abbreviated test can be preferable.
- Surveying technologists: a novel method for establishing productivity standards in a clinical haematology laboratory.
- False-negative rates of tumor metastases in the histologic examination of bone marrow.
- DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells.
- Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: a comparative immunohistochemical study.
- Myeloperoxidase detection by three-color flow cytometry and by enzyme cytochemistry in the classification of acute leukemia.
- Redox-sensitive signaling factors as a novel molecular targets for cancer therapy.
- Increased lymphoblast-like cells following umbilical cord blood stem cell transplantation do not predict recurrent acute leukemia.
- Thioredoxin reductase as a novel molecular target for cancer therapy.
- G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell Carcinomas of the urinary bladder.
- Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell Carcinoma.
- Prognostic variables in male breast cancer.
- Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice.
- Bone pain from granulocyte colony stimulating factor: does clinical trial sponsorship by a pharmaceutical company influence its reporting?
- Side effects and pharmaceutical company bias: adverse event reporting in cancer supportive and palliative care trials.
- Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis.
- Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
- Expression of epidermal growth factor receptor in invasive transitional cell Carcinoma of the urinary bladder. A multivariate survival analysis.
- Fluorescence in Situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears.
- A placebo-controlled, double-blind trial of infliximab for cancer-Associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).
- Is bortezomib, a proteasome inhibitor, effective in treating cancer-Associated weight loss? Preliminary results from the North Central Cancer Treatment Group.
Schools
David Geffen School Of Medicine At UCLA
Santa Clara Valley Medical Center
Procedures Preformed
- Abdominal Hysterectomy
- Adhesiolysis
- Bladder Suspension Surgery
- C-Section
- View All
Conditions Treated
- Atrophic Vaginitis
- Breech Position
- Carcinoma in Situ
- Cervical Polyps
- View All
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Minnesota at Fairview -
Massachusetts General Hospital -
Johns Hopkins University School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Similar Doctors
|
Dr. Khin M. Win, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank D. Deamant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas T. Chou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elisabeth A. Mailhot, MD
This Doctor is OpenDoctor Recommended.
|